Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » lymphoma

lymphoma

May 31, 2013

Qiagen Licenses Two Biomarkers for CDx Development

NEW YORK (GenomeWeb News) – Qiagen today announced two exclusive licensing deals aimed at developing companion diagnostic tests for glioblastoma, lymphoma, and other cancers.

May 28, 2013

CGI Pledges to Launch Two More Array Tests This Year after 'Busy' Q1

Premium

Cancer Genetics said recently that it expects to launch at least two more array-based tests in its blood cancer and urogenital cancer franchises this year: a clinical assay for mantle cell lymphoma, and another, undisclosed test in the urogenital cancer space.

Apr 03, 2013

Insight Genetics to Participate in NCI's Program to Move Assays to Clinical Trials

NEW YORK (GenomeWeb News) – Insight Genetics said Tuesday that it has been chosen by the National Cancer Institute to participate in the institute's Clinical Assay Development Program.

Feb 21, 2013

Dx Focus: Diagnovus Engauge-Cancer-DLBCL; Epigenomics Epi ProColon

Premium

Diagnovus this week launched Engauge-Cancer-DLBCL, a gene expression assay designed to aid physicians with risk stratification and treatment of patients with diffuse large B-cell lymphoma.

Jan 10, 2013

Epizyme Taps Roche to Develop Cobas 4800 CDx for Epizyme/Eisai Lymphoma Drug Candidate

Premium

Epizyme this week announced a collaboration with Eisai and Roche to develop an in vitro, PCR-based companion diagnostic test to help treat genetically defined lymphomas.

Oct 03, 2012

Epizyme Publishes Data Suggesting Compound Activity against Lymphoma with EZH2 Mutations

Premium

Researchers from Epizyme and elsewhere have reported that the company's investigational compound EPZ5687 targets and destroys lymphoma cells harboring mutations in EZH2, a type of histone-modifying enzyme.

Sep 26, 2012

NCI Funds PrimeraDx for Lymphoma Assay

NEW YORK (GenomeWeb News) – PrimeraDx has landed a grant from the National Cancer Institute to develop a gene expression profiling assay that can rapidly detect diffuse large B-Cell lymphoma (DLBCL) subgroups, making it easier to diagnose the disease, select treatment options, and predict the lik

Sep 24, 2012

Mayo, Iowa Land $11.5M for Lymphoma Center

NEW YORK (GenomeWeb News) – Researchers at Mayo Clinic and the University of Iowa have received an $11.5 million grant from the National Cancer Institute to fund translational and clinical projects focused on lymphoma, including genomics-based research.

Aug 15, 2012

Sequenta Tests LymphoSight Assay for Monitoring Residual Disease in Two Clinical Trials

Premium

Sequenta's sequencing assay to measure residual disease is now being tested in two clinical trials for mantle cell lymphoma.

Aug 13, 2012

Researchers ID Pathways Contributing to Burkitt Lymphoma

NEW YORK (GenomeWeb News) – An international team led by investigators at the National Institutes of Health has identified new pathogenic pathways in a form of non-Hodgkin's lymphoma called Burk

Pages

The Scan

Letters Urge Review of Decision to End Coronavirus Grant

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

US Concerns Over BGI Testing in Middle East

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

Confidence Boost

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

Science Studies Describe Machine Learning Algorithm to Speed Mendelian Diagnoses, Safe Drug Response Gene, More

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.